Microbiome-Based Therapeutic For Enhancing Anti-Tumor Immunity In Cancer Treatment
SUMMARY Innovative therapeutic strategy leveraging commensal microbiota, specifically by oral administration of Bifidobacterium, to enhance anti-tumor immunity, potentially improving cancer treatment when combined with checkpoint inhibitors Unmet Need: Only 20-40% of patients respond to immunotherapy while a majority experience… Read More